TAIPEI (Taiwan News) — Two indigenously developed vaccines in Taiwan can provide protection from the novel coronavirus COVID-19 and some of its mutations.
Local vaccine manufacturers Medigen Vaccine Biologics Corp. (高端疫苗) and United Biomedical (聯亞生技) have entered the second phase of clinical trials, involving more than 4,000 people each. The vaccine hopefuls are likely to secure emergency use authorization in June and be rolled out in July.
protection n. 保護
mutation n. 突變
trial n. 試驗